International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes.

Abichou G, Loschi M, Sammut R, Sedaki B, Benachour S, Fileni C, Ferrero-Vacher C, De Pooter N, Mouanes-Abelin J, Dadone-Montaudie B, Cluzeau T

Open source

DOI
10.1159/000549858
Published
2026
Container
Acta haematologica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000549858,
  title = {International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes.},
  author = {Abichou G and Loschi M and Sammut R and Sedaki B and Benachour S and Fileni C and Ferrero-Vacher C and De Pooter N and Mouanes-Abelin J and Dadone-Montaudie B and Cluzeau T},
  year = {2026},
  journal = {Acta haematologica},
  doi = {10.1159/000549858},
  url = {https://doi.org/10.1159/000549858}
}

RIS

TY  - JOUR
TI  - International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes.
AU  - Abichou G
AU  - Loschi M
AU  - Sammut R
AU  - Sedaki B
AU  - Benachour S
AU  - Fileni C
AU  - Ferrero-Vacher C
AU  - De Pooter N
AU  - Mouanes-Abelin J
AU  - Dadone-Montaudie B
AU  - Cluzeau T
PY  - 2026
JO  - Acta haematologica
DO  - 10.1159/000549858
UR  - https://doi.org/10.1159/000549858
ER  - 

APA

G, A., M, L., R, S., B, S., S, B., C, F., C, F., N, D. P., J, M., B, D., & T, C. (2026). International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes.. Acta haematologica. https://doi.org/10.1159/000549858

Source records